Wellness by Science Attacks Obesity and Type 2 Diabetes with Genomic-Based Plans
Genomic testing underlies the company’s plans to reverse or prevent obesity and type 2 diabetes without medication or surgery.
Read MorePosted by Steve Halasey | Jul 20, 2018 | Diagnostic Technologies |
Genomic testing underlies the company’s plans to reverse or prevent obesity and type 2 diabetes without medication or surgery.
Read MorePosted by Steve Halasey | Jul 3, 2018 | Cerebrovascular, Software, Stroke |
Together, the companies will offer a comprehensive point-of-care portfolio for diabetes management.
Read MorePosted by Steve Halasey | Jun 15, 2018 | Diagnostic Technologies |
The WHO catalog of essential diagnostic tests includes the tests needed to diagnose most common conditions as well as a number of global priority diseases.
Read MorePosted by Steve Halasey | Jun 12, 2018 | Pancreatic, Research |
Designed to validate Immunovia’s blood-based test for familial pancreatic cancer risk, the study will analyze more than 1,000 individuals across sites in the United States and Europe.
Read MorePosted by Steve Halasey | Jun 12, 2018 | Cameras, Culture Media, Software |
The partners’ patient-centered solution offers physicians more control over patient care by accomplishing testing and satisfying value-based quality measures during a single visit.
Read More